Showing 1 - 20 results of 45 for search 'von Kleist, S', query time: 0.07s Refine Results
  1. 1
    O loutkovém divadle

    O loutkovém divadle by Heinrich von Kleist

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Sobre la elaboración del pensamiento (1805).

    Sobre la elaboración del pensamiento (1805). by Henrich Von Kleist

    Published 1997-01-01
    Get full text
    Article
  3. 3
    Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV

    Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV by Sara Iannuzzi, Max von Kleist

    Published 2021-07-01
    Get full text
    Article
  4. 4
    Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV

    Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV by Max von Kleist, Max von Kleist, J. Gerardo García-Lerma, Albert Liu, Peter L. Anderson

    Published 2020-08-01
    Get full text
    Article
  5. 5
    Multiscale Systems‐Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV‐1

    Multiscale Systems‐Pharmacology Pipeline to Assess the Prophylactic Efficacy of NRTIs Against HIV‐1 by S Duwal, V Sunkara, M von Kleist

    Published 2016-07-01
    Get full text
    Article
  6. 6
    Numerical approaches for the rapid analysis of prophylactic efficacy against HIV with arbitrary drug-dosing schemes.

    Numerical approaches for the rapid analysis of prophylactic efficacy against HIV with arbitrary drug-dosing schemes. by Lanxin Zhang, Junyu Wang, Max von Kleist

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Drug-class specific impact of antivirals on the reproductive capacity of HIV.

    Drug-class specific impact of antivirals on the reproductive capacity of HIV. by Max von Kleist, Stephan Menz, Wilhelm Huisinga

    Published 2010-03-01
    Get full text
    Article
  8. 8
    Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection.

    Correction: Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection. by Sulav Duwal, Christof Schütte, Max von Kleist

    Published 2012-01-01
    Get full text
    Article
  9. 9
    Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.

    Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection. by Sulav Duwal, Christof Schütte, Max von Kleist

    Published 2012-01-01
    Get full text
    Article
  10. 10
    Correction: Klauser et al. Line Tension and Drop Size Dependence of Contact Angle at the Nanoscale. <i>Nanomaterials</i> 2022, <i>12</i>, 369

    Correction: Klauser et al. Line Tension and Drop Size Dependence of Contact Angle at the Nanoscale. <i>Nanomaterials</i> 2022, <i>12</i>, 369 by Waldemar Klauser, Fabian T. von Kleist-Retzow, Sergej Fatikow

    Published 2023-10-01
    Get full text
    Article
  11. 11
    Line Tension and Drop Size Dependence of Contact Angle at the Nanoscale

    Line Tension and Drop Size Dependence of Contact Angle at the Nanoscale by Waldemar Klauser, Fabian T. von Kleist-Retzow, Sergej Fatikow

    Published 2022-01-01
    Get full text
    Article
  12. 12
    Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis.

    Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis. by Sulav Duwal, Laura Dickinson, Saye Khoo, Max von Kleist

    Published 2019-01-01
    Get full text
    Article
  13. 13
    HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection.

    HIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selection. by Max von Kleist, Philipp Metzner, Roland Marquet, Christof Schütte

    Published 2012-01-01
    Get full text
    Article
  14. 14
    Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes.

    Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes. by Sulav Duwal, Laura Dickinson, Saye Khoo, Max von Kleist

    Published 2018-06-01
    Get full text
    Article
  15. 15
    COVIDStrategyCalculator: A software to assess testing and quarantine strategies for incoming travelers, contact management, and de-isolation

    COVIDStrategyCalculator: A software to assess testing and quarantine strategies for incoming travelers, contact management, and de-isolation by Wiep van der Toorn, Djin-Ye Oh, Max von Kleist

    Published 2021-06-01
    Get full text
    Article
  16. 16
    The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis

    The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis by Sulav Duwal, Daniel Seeler, Laura Dickinson, Saye Khoo, Max von Kleist

    Published 2019-03-01
    Get full text
    Article
  17. 17
    Advances in assembled micro- and nanoscale mechanical contact probes

    Advances in assembled micro- and nanoscale mechanical contact probes by James L. Mead, Waldemar Klauser, Fabian von Kleist-Retzow, Sergej Fatikow

    Published 2022-09-01
    Get full text
    Article
  18. 18
    Multi-Input data ASsembly for joint Analysis (MIASA): A framework for the joint analysis of disjoint sets of variables

    Multi-Input data ASsembly for joint Analysis (MIASA): A framework for the joint analysis of disjoint sets of variables by Nomenjanahary Alexia Raharinirina, Vikram Sunkara, Max von Kleist, Konstantin Fackeldey, Marcus Weber

    Published 2024-01-01
    Get full text
    Article
  19. 19
    HIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirs.

    HIV quasispecies dynamics during pro-active treatment switching: impact on multi-drug resistance and resistance archiving in latent reservoirs. by Max von Kleist, Stephan Menz, Hartmut Stocker, Keikawus Arasteh, Christof Schütte, Wilhelm Huisinga

    Published 2011-03-01
    Get full text
    Article
  20. 20
    Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany

    Dynamics of HIV PrEP use and coverage during and after COVID-19 in Germany by Daniel Schmidt, Yannick Duport, Christian Kollan, Ulrich Marcus, Sara Iannuzzi, Max von Kleist

    Published 2024-06-01
    Get full text
    Article

Search Tools: